O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.47B
AUM Growth
-$1.57B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
145
New
Increased
Reduced
Closed

Top Buys

1
+$95.1M
2
+$76.2M
3
+$74M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$72.1M
5
LLY icon
Eli Lilly
LLY
+$66.8M

Top Sells

1
+$205M
2
+$143M
3
+$75.8M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$56.3M
5
BMY icon
Bristol-Myers Squibb
BMY
+$49.2M

Sector Composition

1 Healthcare 90.2%
2 Financials 0.22%
3 Technology 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$13.2M 0.14%
326,000
+41,000
77
$12.7M 0.13%
+1,890,400
78
$12.7M 0.13%
660,900
-68,700
79
$12.2M 0.13%
1,300,000
80
$12.1M 0.13%
1,276,190
81
$12.1M 0.13%
77,200
-272,172
82
$11.8M 0.12%
5,260
83
$11.8M 0.12%
90,000
84
$11.6M 0.12%
549,680
+20,311
85
$11.3M 0.12%
2,305,446
+33,946
86
$11.1M 0.12%
+220,499
87
$11M 0.12%
106,090
-45,114
88
$10.9M 0.12%
40,579
-9,170
89
$10.3M 0.11%
347,750
+241,500
90
$10.1M 0.11%
+345,000
91
$10.1M 0.11%
+757,365
92
$9.91M 0.1%
237,000
+26,000
93
$9.63M 0.1%
350,000
94
$9.62M 0.1%
230,000
95
$9.51M 0.1%
3,802,000
96
$9.29M 0.1%
135,750
97
$8.54M 0.09%
76,000
+9,000
98
$8.17M 0.09%
+294,000
99
$8.12M 0.09%
+128,300
100
$7.33M 0.08%
249,400
-254,900
2 3
4
5 6